Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 275 No 7368 p370
24 September 2005

This article
Reprint   Photocopy

PDF 110K, Acrobat Reader

Letters

· Prescribing (2)
· Compliance (2)
· Residential care
· Metered dosage systems
· Reciprocity
· Proton pump inhibitors
· Registration examination
· The Society (3)
· New pharmacy contract


Letters to the Editor

Reciprocity

End of agreement — alternative suggestion

From Mr R. W. Nash, MRPharmS

In The Journal of the 27 August (p268) was the announcement that the Privy Council had approved ending reciprocal registration rights with long-term friends of the UK: Australia, New Zealand and South Africa. Why were such draconian and discriminatory measures necessary?

At about the time the measure was going to the Privy Council, the British and Australian prime ministers were discussing further co-operation between their two countries. The Royal Pharmaceutical Council’s move hardly seems to be in the spirit of co-operation. Are similar provisions going to apply to doctors, dentists and allied health professionals?

One wonders who dreamt up the measures. One also ponders about which member (if any) of the Council travelled to Australia or New Zealand to gauge their standard of education or practice of pharmacy? After all, the Council now assumes that their standards are a year lower than those of the UK — they are of course comparable to those of the UK. Did anyone go into a pharmacy and peer around? Had they done so, they might have been embarrassed. For one thing there is not the abject waste associated with the British system.

Perhaps the members of the Society thought they might get cheap labour by using skilled pharmacists from the Antipodes during their compulsory training before registration, but this is unlikely to happen. A recent article in the Australian Journal of Pharmacy said that Australian women pharmacists would be better off working as bar attendants.

There can be no argument with competency based registration, unless you come from the EU of course, where (no doubt) standards must be as high as those of the UK, otherwise their graduates would not be able to enter the UK. My understanding is that Canada now requires proof of experience and passing an entrance examination. Australian registration boards have had a similar approach: proof of a year’s experience and passing an entrance examination, although this is now likely to change. The Australian examination can also be done overseas.

Would not a more sensible approach be for the Council to negotiate common requirements with the Canadian and Australian registration boards? A realistic approach was outlined on p216 of The Journal, on 20 August.

Rob Nash
Dunoon, Argyll

Send your letter to The Editor

Previous Topic (Metered dosage systems)
Next Topic (Proton pump inhibitors)

Back to Top


©The Pharmaceutical Journal